Cargando…
Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects
Since bromodomain containing 4 (brd4) has been considered as a prominent cancer target, numerous attempts have been made to develop potent brd4 bromodomain inhibitors. The present study provided a novel chemical scaffold which inhibited brd4 activity. Mid-throughput screening against brd4 bromodomai...
Autores principales: | Kim, Young Hun, Kim, Minsung, Kim, Ji Eun, Yoo, Miyoun, Lee, Heung Kyoung, Lee, Chong Ock, Yoo, Minjin, Jung, Kwan-Young, Kim, Yeongrin, Choi, Sang Un, Park, Chi Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063330/ https://www.ncbi.nlm.nih.gov/pubmed/33907583 http://dx.doi.org/10.3892/ol.2021.12734 |
Ejemplares similares
-
Synthesis and Structure–Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research
por: Yoo, Minjin, et al.
Publicado: (2021) -
Crystal structure of [1,2,4]
triazolo[4,3-
b
]pyridazine derivatives as BRD4 bromodomain inhibitors and structure–activity relationship study
por: Kim, Jung-Hoon, et al.
Publicado: (2023) -
Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer
por: Kim, Minsung, et al.
Publicado: (2018) -
c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
por: Kang, Chung Hyo, et al.
Publicado: (2021) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)